Recent advances in matrix metalloproteinase inhibitor research
- 31 January 1996
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 1 (1), 16-26
- https://doi.org/10.1016/1359-6446(96)89115-x
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Inhibition of metalloproteinase by futoenone derivativesBioorganic & Medicinal Chemistry Letters, 1995
- Crystal structures of matrilysin-inhibitor complexesBiochemistry, 1995
- Determination of Pharmacophoric Geometry for Collagenase Inhibitors Using a Novel Computational Method and Its Verification Using Molecular Dynamics, NMR, and X-ray CrystallographyJournal of the American Chemical Society, 1995
- Inhibition of the metastatic spread and growth of B16‐BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitorInternational Journal of Cancer, 1994
- Matrix Metalloproteinase Inhibitors Containing a [(Carboxyalkyl)amino]zinc Ligand: Modification of the P1 and P2' ResiduesJournal of Medicinal Chemistry, 1994
- Inhibition of metalloproteinase activity of rheumatoid arthritis synovial cells by a new inhibitor [BE16627B;l-N-(N-hydroxy-2-isobutylsuccinamoyl)-seryl-l-valine]Inflammation Research, 1993
- Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin)Biochemistry, 1993
- Inhibition of collagenase by aranciamycin and aranciamycin derivatives.Journal of Medicinal Chemistry, 1992
- Proteolytic inactivation of human α1 antitrypsin by human stromelysinFEBS Letters, 1991
- A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomasNature, 1990